![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Duarte J. Ocete M.A. Perez-Vizcaino F. Zarzuelo A. Tamargo J.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.338, Iss.1, 1997-10, pp. : 25-33
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Selective tyrosine kinase inhibitors
Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Nitric oxide synthase inhibitors
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. :